Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,375
Closed -$220K 73
2015
Q1
$220K Hold
1,375
0.27% 68
2014
Q4
$219K Buy
+1,375
New +$214K 0.24% 73
2014
Q3
Sell
-21,756
Closed -$2.58M 86
2014
Q2
$2.58M Sell
21,756
-167
-0.8% -$19.3K 2.14% 9
2014
Q1
$2.7M Buy
+21,923
New +$2.66M 2.49% 8

Other funds holding AMGN

Portola Group's AMGN Position: Q2 2015 in Review

Portola Group sold out of Amgen (AMGN) in Q2 2015, closing a stake of 1,375 shares — an estimated $220K sold.

Portola Group first reported a position in AMGN in Q1 2014 and held it in 4 quarters. The position peaked at $2.7M in Q1 2014. 1,367 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

  • Portola Group reported no remaining Amgen position as of Q2 2015 after selling out during the quarter.
  • Portola Group sold 1,375 Amgen shares in Q2 2015, an estimated $220K.
  • Portola Group first reported a position in Amgen in Q1 2014 and held it in 4 quarters.
  • Portola Group's Amgen position peaked at $2.7M in Q1 2014.
  • 1,367 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Portola Group's 13F filing for Q2 2015, filed 17 Jul 2015.